{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "PRE", "regularMarketPrice": 0.0178, "exchangeTimezoneShortName": "EDT", "exchangeTimezoneName": "America/New_York", "currency": "USD", "market": "us_market", "esgPopulated": false, "messageBoardId": "finmb_301198801", "gmtOffSetMilliseconds": -14400000, "shortName": "Lucira Health, Inc.", "longName": "Lucira Health, Inc.", "regularMarketChangePercent": 10.558999, "exchange": "PNK", "regularMarketChange": 0.001699999, "regularMarketTime": 1684179077, "regularMarketDayHigh": 0.0199, "regularMarketDayRange": "0.0144 - 0.0199", "regularMarketDayLow": 0.0144, "regularMarketVolume": 314638, "regularMarketPreviousClose": 0.0161, "fullExchangeName": "Other OTC", "financialCurrency": "USD", "regularMarketOpen": 0.0184, "averageDailyVolume3Month": 16084753, "averageDailyVolume10Day": 443950, "fiftyTwoWeekLowChange": 0.0037999991, "averageAnalystRating": "3.0 - Hold", "tradeable": false, "cryptoTradeable": false, "fiftyTwoWeekLowChangePercent": 0.2714285, "fiftyTwoWeekRange": "0.014 - 3.58", "fiftyTwoWeekHighChange": -3.5621998, "fiftyTwoWeekHighChangePercent": -0.9950279, "fiftyTwoWeekLow": 0.014, "fiftyTwoWeekHigh": 3.58, "earningsTimestampStart": 1684753140, "earningsTimestampEnd": 1686052800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.15, "epsForward": -0.48, "sharesOutstanding": 40599000, "bookValue": 1.505, "fiftyDayAverage": 0.17242, "fiftyDayAverageChange": -0.15461999, "fiftyDayAverageChangePercent": -0.8967637, "twoHundredDayAverage": 0.79069, "twoHundredDayAverageChange": -0.77289003, "twoHundredDayAverageChangePercent": -0.97748804, "marketCap": 1191717, "forwardPE": -0.03708333, "priceToBook": 0.011827243, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "firstTradeDateMilliseconds": 1612535400000, "priceHint": 4, "displayName": "Lucira Health", "symbol": "LHDXQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1412 62nd Street", "city": "EmeryVille", "state": "CA", "zip": "94608", "country": "United States", "phone": "510 350 8071", "website": "https://www.lucirahealth.com", "industry": "Medical Devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.", "fullTimeEmployees": 221, "companyOfficers": [{"maxAge": 1, "name": "Greg  Chodaczek", "title": "Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nadine  Greiner Ph.D.", "title": "Chief HR Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 10, "boardRisk": 10, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1682899200, "maxAge": 86400}}], "error": null}}